Aespire Formulations Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2013.
2013 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Aespire Formulations Private Limited

Aespire Formulations Private Limited, a active private limited company, was established on 26 November 2013 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900DL2013PTC260979. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Asmira Healthcare Private Limited. It upholds a compliant status. Employing 5 professional, Its leadership includes Anupama Sarkar (Director), Rajat Sood (Director), Suman Sood (Director). Past directors included Rajat Sood. It holds ₹4.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 403, Fourth Floor Building No 49, 50 Red Rose, Nehru Place, New Delhi, Delhi, 110019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900DL2013PTC260979

  • Registration Number

    260979

  • Incorporation Date

    26 November 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.50 M
  • Revenue Growth **** -8.47%
  • Profit Growth **** 204.32%
  • Ebitda **** 467.22%
  • Net Worth 17.37%
  • Total Assets -8.54%
Company report

Aespire Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aespire Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aespire Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Anupama Sarkar Director 26 Nov 2013 Current
Rajat Sood Director 26 May 2016 Current
Suman Sood Director 26 Nov 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aespire Formulations.

Aespire Formulations Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.47% decrease. The company also saw a substantial improvement in profitability, with a 204.32% increase in profit. The company's net worth Soared by an impressive increase of 17.37%.

Aespire Formulations revenue growth over time
Aespire Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -8.47%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.05%
*******
*******
*******
*******
Total Assets
*******
 -8.54%
*******
*******
*******
*******
Profit or Loss
*******
 204.32%
*******
*******
*******
*******
Net Worth
*******
 17.37%
*******
*******
*******
*******
EBITDA
*******
 467.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aespire Formulations?

In 2021, Aespire Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.45 Cr
Latest Charge Details
Date Lender Amount Status
30 May 2017 Hdfc Bank Limited ₹4.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Aespire Formulations?

Aespire Formulations has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aespire Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aespire Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aespire Formulations
Recent Activity within the Organization
  • Annual General Meeting

    The activity Aespire Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Aespire Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was completed.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 4.50 M registered on 30 May 2017 with Charge ID 100119133 was modified on 22 Feb 2021. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 4.50 M with Charge ID 100119133 was registered on 30 May 2017. was documented.

  • Director Appointment

    Progress on Rajat Sood was appointed as a Director was appointed as a Director on 26 May 2016 & has been associated with this company since 9 years 9 months . was documented.

  • Director Appointment

    Anupama Sarkar was appointed as a Director was appointed as a Director on 26 Nov 2013 & has been associated with this company since 12 years 3 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aespire Formulations Private Limited?

The CIN of Aespire Formulations Private Limited is U74900DL2013PTC260979.

Where is Aespire Formulations Private Limited headquartered?

Aespire Formulations Private Limited is headquartered at 403, Fourth Floor Building No 49, 50 Red Rose, Nehru Place, New Delhi, Delhi, 110019.

When was Aespire Formulations Private Limited incorporated?

Aespire Formulations Private Limited was incorporated on 26 November 2013.

Who are the current directors of Aespire Formulations Private Limited?

The current directors of Aespire Formulations Private Limited are

What is the primary industry of Aespire Formulations Private Limited?

The primary industry of Aespire Formulations Private Limited is Trade.

Is Aespire Formulations Private Limited a listed company?

Aespire Formulations Private Limited is unlisted.

What is the capital structure of Aespire Formulations Private Limited?

The authorized capital of Aespire Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Aespire Formulations Private Limited?

The compliance status of Aespire Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available